Strategies for successful collaborations and alliances in drug discovery
Shah, S.
Idrugs the Investigational Drugs Journal 5(10): 977-978
2002
ISSN/ISBN: 1369-7056 PMID: 14689941 Document Number: 550529
Document emailed within 1 workday
Related Documents
Nassar, A-Eldin.F.; Lopez-Anaya, A. 2004: Strategies for dealing with reactive intermediates in drug discovery and development Current Opinion in Drug Discovery and Development 7(1): 126-136Bolgár, B.; Arany, Ádám.; Temesi, G.; Balogh, Bázs.; Antal, Péter.; Mátyus, Péter. 2013: Drug repositioning for treatment of movement disorders: from serendipity to rational discovery strategies Current Topics in Medicinal Chemistry 13(18): 2337-2363
Kojima, H.; Okabe, T.; Nagano, T. 2013: Open innovation center for drug discovery: a research-supporting network for drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(6): 327-332
Fujita, Y. 2013: Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 89-95
Shen, Y. 2007: Discovery on Target 2007--CHI's Fifth Annual Conference. RNAi for Drug Discovery and Therapeutics IDrugs: the investigational drugs journal 10(12): 848-850
Young, S.S. 1999: Discovery 99: accelerate and improve the drug discovery process. 26-29 April 1999, San Diego, CA, USA IDrugs: the investigational drugs journal 2(7): 648-649
Kashyap, A.; Singh, P.Kumar.; Silakari, O. 2018: Counting on Fragment Based Drug Design Approach for Drug Discovery Current Topics in Medicinal Chemistry 18(27): 2284-2293
Alhenc-Gelas, Fçois.; Parmentier, L.; Bisagni, A. 2003: Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development Therapie 58(3): 275-282
Emilien, G.; Maloteaux, J.M. 1998: Pharmacological management of epilepsy. Mechanism of action, pharmacokinetic drug interactions, and new drug discovery possibilities International Journal of Clinical Pharmacology and Therapeutics 36(4): 181-194
Armetti, L. 1999: Round table: The Italian Pharmacology Society and the drug industry: new processes in drug discovery and the contribution of universities Bollettino chimico farmaceutico 138(11): 596-598
Bittner, B.; Mountfield, R.J. 2002: Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters Current Opinion in Drug Discovery and Development 5(1): 59-71
Williams, M. 2003: Genome-based drug discovery: prioritizing disease-susceptibility/disease-associated genes as novel drug targets for schizophrenia Current Opinion in Investigational Drugs 4(1): 31-36
Hulsebosch, C.E. 2005: From discovery to clinical trials: treatment strategies for central neuropathic pain after spinal cord injury Current Pharmaceutical Design 11(11): 1411-1420
Purandare, B. 2015: Successful Management of Highly Drug-Resistant Tuberculosis with Individualized Drug Susceptibility Testing Journal of the Association of Physicians of India 63(7): 94-95
1996: Redesigning drug discovery Nature 384(6604 Suppl): 1-5
Jarrard, D. 2014: What to say, when to say it. Set the tone for a successful merger with five strategies for communication Trustee: the Journal for Hospital Governing Boards 67(3): 30
Bear, K.; Tigges, B.B. 1993: Management strategies for promoting successful breastfeeding Nurse Practitioner 18(6): 50; 53
McGowan, J.; Hoth, D. 1989: AIDS drug discovery and development Journal of Acquired Immune Deficiency Syndromes 2(4): 335-343
Frigeri, A.; Nicchia, G.Paola.; Svelto, M. 2007: Aquaporins as targets for drug discovery Current Pharmaceutical Design 13(23): 2421-2427
Bleicher, K.H. 2002: Chemogenomics: bridging a drug discovery gap Current Medicinal Chemistry 9(23): 2077-2084